• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

New Platelet Transfusion Guidelines from the International Collaboration for Transfusion Medicine

February 6, 2015

117157483Platelet transfusions for hematology-oncology patients undergoing chemotherapy or stem cell transplants with hypoproliferative thrombocytopenia are common.

New platelet transfusion guidelines from the International Collaboration for Transfusion Medicine (ICTM) assist specialists in maximizing platelet resources.  The ICTM recommends that prophylactic platelet transfusions should be given to chemotherapy or stem cell transplant patients when platelet counts are 10X109/L or lower, or if these patients have significant bleeding.  Although lower, more frequent doses of platelets (1.1X1011/m2) were found to be just as effective as higher doses for inpatients, median doses (2.4X1011/m2) may help lower costs and prevent clinic visits for outpatients.  The ICTM also recommends using ABO-matched platelets. Women of child bearing potential who are RhD negative should be given Rh immunoglobin if they receive RhD positive platelets.  Hypoproliferative thrombocytopenic patients who are refractory to platelet transfusions due to alloimmunization should receive HLA/HPA-selected or cross-matched-selected platelets, although the exact degree of benefit is not clear.  These recommendations are in-line with the current AABB guidelines for platelet transfusions that were recently published.

References

1. Dzik S, Murphy MF. Clinical guidelines in transfusion medicine. Transfus Med Rev 2015;29: 1-2.
2. Nahirniak S, Slichter SJ, Tanael S, Rebulla P, Pavenski K, Vassallo R, Fung M, Duquesnoy R, Saw CL, Stanworth S, Tinmouth A, Hume H, Ponnampalam A, Moltzan C, Berry B, Shehata N, International Collaboration for Transfusion Medicine G. Guidance on Platelet Transfusion for Patients With Hypoproliferative Thrombocytopenia. Transfus Med Rev 2015;29: 3-13.
3. Kaufman RM, Djulbegovic B, Gernsheimer T, Kleinman S, Tinmouth AT, Capocelli KE, Cipolle MD, Cohn CS, Fung MK, Grossman BJ, Mintz PD, O’Malley BA, Sesok-Pizzini DA, Shander A, Stack GE, Webert KE, Weinstein R, Welch BG, Whitman GJ, Wong EC, and Tobian AAR.  Platelet transfusion: a clinical practice guideline from the AABB.  Annals of Internal Medicine 2015; 162:205-213.

 

Filed Under

  • News
  • Platelet Transfusion
  • Policy and Guidelines

Recommended

  • RBCeq: A Novel, User-Friendly, Algorithm for Genetic Blood Typing

  • Peginesatide Recalled After Serious Reactions Reported

  • Chronic Lymphocytic Leukemia is not Transmitted through Transfusions

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley